Christopher Michael Nemes

Christopher Nemes practices at Glaucoma Consultants of the Bay Area a Med Corp in San Francisco, California.

Christopher Nemes' NPI, 1851772719, was assigned on June 16, 2015. Christopher Nemes graduated from University of Manchester Faculty of Medicine in 2013. Christopher Nemes' Pennsylvania license number on file is MT208699.

Christopher Nemes' primary practice is Glaucoma Consultants of the Bay Area a Med Corp, at 2211 Post St, San Francisco, CA 94115 in San Francisco County. The practice phone is (415) 771-4020.

Christopher Nemes' primary practice is Glaucoma Consultants of the Bay Area a Med Corp in San Francisco, California. The medical group on file is UCSF Medical Group. Dmand AI also links Christopher Nemes to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Nemes practices. Vendor and product names are available with a free account.

Psychiatry is Christopher Nemes' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Christopher Nemes is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Christopher Nemes' licenses on file in 4 states: Pennsylvania, California, Hawaii and Washington.

Dmand AI lists adjustment disease, anxiety, bipolar disorder, depression, insomnia and schizophrenia among the conditions Christopher Nemes treats.

CMS data shows 569 Medicare services from Christopher Nemes across 2 procedure codes in 2024, for 40 Medicare patients. Medicare paid $50,337 for them. Every service was in an office.

CMS counts 40 Medicare patients who saw Christopher Nemes in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have mood disorders, and 73% have depression. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Christopher Nemes' median patient age at 45, with 52% women.

In 2024, Christopher Nemes wrote 1,378 Medicare Part D claims for 75 patients. 95% of them were for generic drugs. CMS names the drug for 1,182 of them, across 29 drugs with 11 or more claims each, at $60,456 in total drug cost. In 2023, CMS named 1,005 claims across 30 drugs.

Christopher Nemes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Nemes as offering telehealth.

CMS Open Payments shows 32 general payments to Christopher Nemes from 6 drug and device companies from 2018 to 2023. Food and beverage make up the largest share, 100% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $390.

Christopher Nemes graduated from University of Manchester Faculty of Medicine in 2013.

Christopher Nemes is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.